Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Med Oncol. 2011 Mar 12;29(2):1005–1009. doi: 10.1007/s12032-011-9894-z

Table 1.

Baseline demographics (n = 57)

Mean age at treatment, in years (range) 59 (26–84)a
Sex
 Male 30 (53)
 Female 27 (47)
Had chemotherapy been administered prior to bevacizumab?
 Yes 40 (70)
 No 17 (30)
Weight loss at time of cancer diagnosis?
 Yes 14 (25)
 No 15 (26)
 Unknown 28 (49)
Diabetes?
 Yes 10 (18)
 No 47 (82)
a

Numbers in parentheses refer to the percentage of the cohort unless otherwise specified